Bogac Ercig

发表

Rational modulator design by exploitation of protein-protein complex structures.

K. Wichapong, H. Poelman, Bogac Ercig, 2019, Future medicinal chemistry.

Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic Purpura

Bogac Ercig, É. Azoulay, L. Galicier, 2020, HemaSphere.

Conformational plasticity of ADAMTS13 in hemostasis and autoimmunity

J. Voorberg, K. Wichapong, Bogac Ercig, 2021, The Journal of biological chemistry.

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers

J. Voorberg, Bogac Ercig, J. Hrdinova, 2018, Haematologica.

Child‐onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13

Bogac Ercig, G. Nicolaes, H. Deckmyn, 2018, European journal of haematology.

Insights into 3D Structure of ADAMTS13: A Stepping Stone towards Novel Therapeutic Treatment of Thrombotic Thrombocytopenic Purpura

C. Reutelingsperger, J. Voorberg, K. Wichapong, 2018, Thrombosis and Haemostasis.

Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear

J. Voorberg, K. Wichapong, Bogac Ercig, 2022, International journal of molecular sciences.

Both Reactivity and Accessibility Are Important in Cytochrome P450 Metabolism: A Combined DFT and MD Study of Fenamic Acids in BM3 Mutants

Lars Olsen, Flemming Steen Jørgensen, Rasmus Leth, 2019, J. Chem. Inf. Model..

Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura.

J. Voorberg, Bogac Ercig, G. Nicolaes, 2019, Haematologica.